Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumab

INTRODUCTION: We sought to determine the level of activation of the critical components of the cyclin D1-mediated pathway and to evaluate their prognostic significance across the different molecular subtypes of advanced breast cancer. PATIENTS AND METHODS: The study population comprised 219 female p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mountzios, G, Kotoula, Vassiliki, Kolliou, Georgia-Angeliki, Papadopoulou, Kyriaki, Lazaridis, Georgios, Christodoulou, Christos, Pentheroudakis, George, Skondra, Maria, Koutras, Angelos, Linardou, Helena, Razis, Evangelia, Papakostas, Pavlos, Chrisafi, Sofia, Aravantinos, Gerasimos, Nicolaou, Irene, Goussia, Anna, Kalogeras, Konstantine, Pectasides, Dimitrios, Fountzilas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555606/
https://www.ncbi.nlm.nih.gov/pubmed/31231556
http://dx.doi.org/10.1136/esmoopen-2018-000441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555606/
https://www.ncbi.nlm.nih.gov/pubmed/31231556
http://dx.doi.org/10.1136/esmoopen-2018-000441

Ejemplares similares